A case of high-risk AML in a patient with advanced systemic mastocytosis.
Manlio FazioCalogero VetroUros MarkovicAndrea DuminucoMarina ParisiCinzia MaugeriElisa MauroNunziatina Laura ParrinelloFabio StagnoLoredana VillariAnna Maria TrioloStefania StellaGiuseppe A PalumboFrancesco Di RaimondoAlessandra RomanoRoberta ZanottiPublished in: Clinical case reports (2023)
Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine-venetoclax-midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.